These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
(State or other jurisdiction of
incorporation or organization)
|
(I.R.S. Employer
Identification Number)
|
|
|
|
N/A
|
|
(Address of principal executive offices)
|
(Zip Code)
|
|
Title of Each Class
|
|
Trading Symbol(s)
|
|
Name of Each Exchange on Which Registered
|
|
|
|
|
|
Large accelerated filer
|
☐
|
Accelerated filer
|
☐
|
|
|
☒
|
Smaller reporting company
|
|
|
Emerging growth company
|
|
||
|
Page
|
|
|
Explanatory Note
|
|
|
Cautionary Note Regarding Forward-Looking Statements
|
|
|
PART I
|
|
|
Item 1. Business
|
|
|
Item 1A. Risk Factors
|
|
|
Item 1B. Unresolved Staff Comments
|
|
|
Item 1C. Cybersecurity
|
|
|
Item 2. Properties
|
|
|
Item 3. Legal Proceedings
|
|
|
Item 4. Mine Safety Disclosures
|
|
|
PART II
|
|
|
Item 5. Market for the Registrant’s Common Equity, Related Shareholder Matters and Issuer Purchases of Equity Securities
|
|
|
Item 6. [Reserved]
|
|
|
Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations
|
|
|
Item 7A. Quantitative and Qualitative Disclosures About Market Risk
|
|
|
Item 8. Financial Statements and Supplementary Data
|
|
|
Item 9. Changes in and Disagreements with Accountants on Accounting and Financial Disclosure
|
|
|
Item 9A. Controls and Procedures
|
|
|
Item 9B. Other Information
|
|
|
Item 9C. Disclosure Regarding Foreign Jurisdictions that Prevent Inspections
|
|
|
PART III
|
|
|
Item 10. Directors, Executive Officers and Corporate Governance
|
|
|
Item 11. Executive Compensation
|
|
|
Item 12. Security Ownership of Certain Beneficial Owners and Management and Related Shareholder Matters
|
|
|
Item 13. Certain Relationships and Related Transactions, and Director Independence
|
|
|
Item 14. Principal Accounting Fees and Services
|
|
|
PART IV
|
|
|
Item 15. Exhibits and Financial Statement Schedules
|
|
|
Item 16. Form 10-K Summary
|
|
|
Signatures
|
|
Number of Facilities
|
|||||
|
Segment
|
Owned
|
Leased
|
Total
|
||
|
Europe, MEA and APAC
|
163
|
159
|
322
|
||
|
North America
|
247
|
50
|
297
|
||
|
Latin America
|
53
|
5
|
58
|
||
|
Corporate and significant regional offices
|
1
|
5
|
6
|
||
|
Total
(1)
|
464
|
219
|
683
|
||
|
Location of Mill
|
Containerboard
|
Paperboard
|
Kraft Paper
|
Graphic Paper
|
Total
|
||||
|
Pitea, SWE
|
794
|
794
|
|||||||
|
Roermond, NETH
|
717
|
717
|
|||||||
|
Parenco, NETH
|
441
|
248
|
689
|
||||||
|
Facture, FRA
|
634
|
634
|
|||||||
|
Zulpich, GER
|
573
|
573
|
|||||||
|
Verzuolo, ITA
|
551
|
551
|
|||||||
|
Nettingsdorf, AUS
|
507
|
507
|
|||||||
|
Hoya, GER
|
474
|
474
|
|||||||
|
Herzberg, GER
|
287
|
287
|
|||||||
|
Saillat, FRA
|
281
|
281
|
|||||||
|
Mengibar, SPA
|
265
|
265
|
|||||||
|
Wrexen, GER
|
259
|
259
|
|||||||
|
Townsend Hook, UK
|
259
|
259
|
|||||||
|
Ania, ITA
|
254
|
254
|
|||||||
|
SSK, UK
|
220
|
220
|
|||||||
|
Nervion, SPA
|
176
|
176
|
|||||||
|
Morai, IND
|
165
|
165
|
|||||||
|
Belgrade, SER
|
132
|
132
|
|||||||
|
Navarra, SPA
|
94
|
94
|
|||||||
|
Wrexen Board, GER
|
88
|
88
|
|||||||
|
Hoya Board, GER
|
88
|
88
|
|||||||
|
Morava, CZK
|
83
|
83
|
|||||||
|
Rethel, FRA
|
72
|
72
|
|||||||
|
Total Europe, MEA and APAC
|
6,681
|
463
|
270
|
248
|
7,662
|
|
Location of Mill
|
Containerboard
|
Paperboard
|
Kraft Paper
|
Pulp
|
Total
|
||||
|
Mahrt, AL
|
1,031
|
1,031
|
|||||||
|
Longview, WA
|
624
|
351
|
975
|
||||||
|
Fernandina Beach, FL
|
928
|
928
|
|||||||
|
West Point, VA
|
922
|
922
|
|||||||
|
Stevenson, AL
|
864
|
864
|
|||||||
|
Covington, VA
|
793
|
793
|
|||||||
|
Hodge, LA
|
790
|
790
|
|||||||
|
Solvay, NY
|
770
|
770
|
|||||||
|
Florence, SC
|
733
|
733
|
|||||||
|
Seminole, FL
|
620
|
620
|
|||||||
|
Evadale, TX
|
55
|
531
|
586
|
||||||
|
Dublin, GA
|
279
|
305
|
584
|
||||||
|
Roanoke Rapids, NC
|
322
|
196
|
518
|
||||||
|
Demopolis, AL
|
374
|
100
|
474
|
||||||
|
La Tuque, Quebec
|
341
|
127
|
468
|
||||||
|
Hopewell, VA
|
466
|
466
|
|||||||
|
Monterrey, MX
|
402
|
402
|
|||||||
|
Forney, TX
|
354
|
354
|
|||||||
|
Cerro Gordo, MX
|
259
|
88
|
347
|
||||||
|
Guadalajara, MX
|
160
|
110
|
270
|
||||||
|
San Pablo, MX
|
243
|
243
|
|||||||
|
Cowpens, SC
|
234
|
234
|
|||||||
|
Los Reyes, MX
|
158
|
158
|
|||||||
|
St Paul, MN
|
157
|
157
|
|||||||
|
Battle Creek, MI
|
150
|
150
|
|||||||
|
Dallas, TX
|
127
|
127
|
|||||||
|
Missisquoi, VT
|
99
|
99
|
|||||||
|
Stroudsburg, PA
|
72
|
72
|
|||||||
|
San Luis Potosi, MX
|
71
|
71
|
|||||||
|
Monterrey, MX
|
35
|
35
|
|||||||
|
Total North America
|
9,630
|
3,659
|
852
|
100
|
14,241
|
|
Location of Mill
|
Containerboard
|
Paperboard
|
Kraft Paper
|
Total
|
|||
|
Tres Barras, BRA
|
650
|
650
|
|||||
|
Cali, COL
|
129
|
70
|
121
|
320
|
|||
|
Pirapetinga, BRA
|
143
|
143
|
|||||
|
Barbosa, COL
|
127
|
127
|
|||||
|
Bernal, ARG
|
77
|
77
|
|||||
|
Barranquilla, COL
|
77
|
77
|
|||||
|
Uberaba, BRA
|
72
|
72
|
|||||
|
Cnel Suarez, ARG
|
57
|
57
|
|||||
|
Bento, BRA
|
55
|
55
|
|||||
|
Total Latin America
|
1,387
|
70
|
121
|
1,578
|
|
($ in millions)
|
|||||
|
2024
|
2023
|
2022
|
|||
|
Net sales
|
$
21,109
|
$
12,093
|
$
13,509
|
||
|
Cost of goods sold
|
(16,914)
|
(9,039)
|
(10,237)
|
||
|
Gross profit
|
4,195
|
3,054
|
3,272
|
||
|
Selling, general and administrative expenses
|
(2,793)
|
(1,604)
|
(1,543)
|
||
|
Goodwill impairment
|
—
|
—
|
(12)
|
||
|
Impairment of other assets
|
—
|
—
|
(159)
|
||
|
Transaction and integration-related expenses associated with the Combination
|
(395)
|
(78)
|
—
|
||
|
Operating profit
|
1,007
|
1,372
|
1,558
|
||
|
Pension and other postretirement non-service expense, net
|
(24)
|
(49)
|
(8)
|
||
|
Interest expense, net
|
(398)
|
(139)
|
(139)
|
||
|
Other (expense) income, net
|
(25)
|
(46)
|
15
|
||
|
Income before income taxes
|
560
|
1,138
|
1,426
|
||
|
Income tax expense
|
(241)
|
(312)
|
(391)
|
||
|
Net income
|
319
|
826
|
1,035
|
||
|
Less: Net income attributable to noncontrolling interests
|
—
|
(1)
|
(1)
|
||
|
Net income attributable to common shareholders
|
$
319
|
$
825
|
$
1,034
|
||
|
($ in millions)
|
|||
|
2024
|
2023
|
2022
|
|
|
Net sales (aggregate):
(1)
|
|||
|
North America
|
$
10,092
|
$
1,624
|
$
1,720
|
|
Europe, MEA and APAC
|
9,577
|
9,193
|
10,451
|
|
LATAM
|
1,711
|
1,344
|
1,397
|
|
Segment Adjusted EBITDA:
|
|||
|
North America
|
$
1,610
|
$
281
|
$
281
|
|
Europe, MEA and APAC
|
1,529
|
1,684
|
1,920
|
|
LATAM
|
378
|
274
|
280
|
|
Years ended December 31,
|
|||
|
($ in millions)
|
|||
|
2024
|
2023
|
2022
|
|
|
Net cash provided by operating activities
|
$
1,483
|
$
1,559
|
$
1,433
|
|
Net cash used for investing activities
|
$
(2,114)
|
$
(931)
|
$
(1,020)
|
|
Net cash provided by (used for) financing activities
|
$
607
|
$
(479)
|
$
(431)
|
|
Years ended December 31,
|
|||||
|
($ in millions)
|
|||||
|
2024
|
2023
|
2022
|
|||
|
Net income
|
$
319
|
$
826
|
$
1,035
|
||
|
Income tax expense
|
241
|
312
|
391
|
||
|
Depreciation, depletion and amortization
|
1,464
|
580
|
564
|
||
|
Goodwill impairment
|
—
|
—
|
12
|
||
|
Impairment of other assets
|
—
|
—
|
159
|
||
|
Transaction and integration-related expenses associated with the
Combination
|
395
|
78
|
—
|
||
|
Amortization of fair value step up on inventory
|
224
|
—
|
—
|
||
|
Interest expense, net
|
398
|
139
|
139
|
||
|
Pension and other postretirement non-service expense, net
|
24
|
49
|
8
|
||
|
Share-based compensation expense
|
206
|
66
|
68
|
||
|
Other expense (income), net
|
25
|
46
|
(15)
|
||
|
Other adjustments
|
90
|
32
|
29
|
||
|
Adjusted EBITDA
|
$
3,386
|
$
2,128
|
$
2,390
|
||
|
Years ended December 31,
|
|||||
|
($ in millions, except per share data)
|
|||||
|
2024
|
2023
|
2022
|
|||
|
Net income attributable to common shareholders
|
$
319
|
$
825
|
$
1,034
|
||
|
Transaction and integration-related expenses associated with the Combination
|
395
|
78
|
—
|
||
|
Amortization of fair value step up on inventory
|
224
|
—
|
—
|
||
|
Bridge facility fees
|
—
|
10
|
—
|
||
|
Goodwill impairment
|
—
|
—
|
12
|
||
|
Impairment of other assets
|
—
|
—
|
159
|
||
|
Loss on debt extinguishment
|
13
|
—
|
—
|
||
|
Other adjustments
|
90
|
32
|
29
|
||
|
Income tax on items listed above
|
(137)
|
(8)
|
(21)
|
||
|
Adjusted Net Income
|
$
904
|
$
937
|
$
1,213
|
||
|
Earnings per share - Basic
|
$
0.83
|
$
3.19
|
$
4.00
|
||
|
Transaction and integration-related expenses associated with the Combination
|
1.02
|
0.30
|
—
|
||
|
Amortization of fair value step up on inventory
|
0.58
|
—
|
—
|
||
|
Bridge facility fees
|
—
|
0.04
|
—
|
||
|
Goodwill impairment
|
—
|
—
|
0.05
|
||
|
Impairment of other assets
|
—
|
—
|
0.62
|
||
|
Loss on debt extinguishment
|
0.03
|
—
|
—
|
||
|
Other adjustments
|
0.23
|
0.13
|
0.11
|
||
|
Income tax on items listed above
|
(0.35)
|
(0.03)
|
(0.09)
|
||
|
Adjusted Earnings Per Share – Basic
|
$
2.34
|
$
3.63
|
$
4.69
|
||
|
Pension Plans
|
|||
|
50 Basis Point
Increase
|
50 Basis Point
Decrease
|
||
|
Discount rate
|
$
2
|
$
(1)
|
|
|
Compensation level
|
1
|
(1)
|
|
|
Expected long-term rate of return on plan assets
|
(9)
|
9
|
|
|
Page
|
|
|
Report of Independent Registered Public Accounting Firm (Auditor Name
PCAOB ID:
|
|
|
Consolidated Balance Sheets as of
December 31, 2024
and
December 31, 2023
|
|
|
Consolidated Statements of Operations for the years ended
December 31, 2024
,
December 31, 2023
and
December 31,
2022
|
|
|
Consolidated Statements of Comprehensive (Loss) Income for the years ended
December 31, 2024
,
December 31, 2023
and
December 31, 2022
|
|
|
Consolidated Statements of Cash Flows for the years ended
December 31, 2024
,
December 31, 2023
and
December 31,
2022
|
|
|
Consolidated Statements of Changes in Equity for the years ended
December 31, 2024
,
December 31, 2023
and
December 31, 2022
|
|
|
Notes to the Consolidated Financial Statements
|
|
December 31,
2024
|
December 31,
2023
|
||
|
Assets
|
|||
|
Current assets:
|
|||
|
Cash and cash equivalents (amounts related to consolidated variable interest entities of
$
$
|
$
|
$
|
|
|
Accounts receivable, net (amounts related to consolidated variable interest entities of
$
$
|
|
|
|
|
Inventories
|
|
|
|
|
Other current assets
|
|
|
|
|
Total current assets
|
|
|
|
|
Property, plant and equipment, net
|
|
|
|
|
Goodwill
|
|
|
|
|
Intangibles, net
|
|
|
|
|
Prepaid pension asset
|
|
|
|
|
Other non-current assets (amounts related to consolidated variable interest entities of
$
$
|
|
|
|
|
Total assets
|
$
|
$
|
|
|
Liabilities and Equity
|
|||
|
Current liabilities:
|
|||
|
Accounts payable
|
$
|
$
|
|
|
Accrued expenses
|
|
|
|
|
Accrued compensation and benefits
|
|
|
|
|
Current portion of debt
|
|
|
|
|
Other current liabilities
|
|
|
|
|
Total current liabilities
|
|
|
|
|
Non-current debt due after one year
|
|
|
|
|
Deferred tax liabilities
|
|
|
|
|
Pension liabilities and other postretirement benefits, net of current portion
|
|
|
|
|
Other non-current liabilities (amounts related to consolidated variable interest entities of
$
and
$
|
|
|
|
|
Total liabilities
|
|
|
|
|
Commitments and Contingencies (Note 21)
|
|
|
|
|
Equity:
|
|||
|
Preferred stock;
$
outstanding at
December 31, 2024
and
December 31, 2023
, respectively
|
|
|
|
|
Common stock;
$
|
|
|
|
|
Deferred shares,
€
outstanding at
December 31, 2024
and
December 31, 2023
, respectively
|
|
|
|
|
Treasury stock, at cost (
December 31, 2023
respectively)
|
(
|
(
|
|
|
Capital in excess of par value
|
|
|
|
|
Accumulated other comprehensive loss
|
(
|
(
|
|
|
Retained earnings
|
|
|
|
|
Total shareholders’ equity
|
|
|
|
|
Noncontrolling interests
|
|
|
|
|
Total equity
|
|
|
|
|
Total liabilities and equity
|
$
|
$
|
|
|
Years ended December 31,
|
|||||
|
2024
|
2023
|
2022
|
|||
|
Net sales
|
$
|
$
|
$
|
||
|
Cost of goods sold
|
(
|
(
|
(
|
||
|
Gross profit
|
|
|
|
||
|
Selling, general and administrative expenses
|
(
|
(
|
(
|
||
|
Goodwill impairment
|
|
|
(
|
||
|
Impairment of other assets
|
|
|
(
|
||
|
Transaction and integration-related expenses associated with the
Combination
|
(
|
(
|
|
||
|
Operating profit
|
|
|
|
||
|
Pension and other postretirement non-service expense, net
|
(
|
(
|
(
|
||
|
Interest expense, net
|
(
|
(
|
(
|
||
|
Other (expense) income, net
|
(
|
(
|
|
||
|
Income before income taxes
|
|
|
|
||
|
Income tax expense
|
(
|
(
|
(
|
||
|
Net income
|
|
|
|
||
|
Less: Net income attributable to noncontrolling interests
|
|
(
|
(
|
||
|
Net income attributable to common shareholders
|
$
|
$
|
$
|
||
|
Basic earnings per share attributable to common shareholders
|
$
|
$
|
$
|
||
|
Diluted earnings per share attributable to common shareholders
|
$
|
$
|
$
|
||
|
The accompanying notes are an integral part of these Consolidated Financial Statements.
|
|||||
|
Years ended December 31,
|
|||||
|
2024
|
2023
|
2022
|
|||
|
Net income
|
$
|
$
|
$
|
||
|
Other comprehensive (loss) income, net of tax:
|
|||||
|
Foreign currency translation (loss) gain
|
(
|
|
(
|
||
|
Defined benefit pension and other postretirement benefit plans
adjustments
|
|
(
|
|
||
|
Net gains (losses) on cash flow hedging derivatives
|
|
|
(
|
||
|
Other comprehensive (loss) income, net of tax
|
(
|
|
(
|
||
|
Comprehensive (loss) income
|
(
|
|
|
||
|
Less: Comprehensive income attributable to noncontrolling interests
|
|
(
|
(
|
||
|
Comprehensive (loss) income attributable to common shareholders
|
$
(
|
$
|
$
|
||
|
The accompanying notes are an integral part of these Consolidated Financial Statements.
|
|||||
|
Years ended December 31,
|
|||||
|
2024
|
2023
|
2022
|
|||
|
Operating activities:
|
|||||
|
Net income
|
$
|
$
|
$
|
||
|
Adjustments to reconcile consolidated net income to net cash provided by operating
activities:
|
|||||
|
Depreciation, depletion and amortization
|
|
|
|
||
|
Cash surrender value increase in excess of premiums paid
|
(
|
|
|
||
|
Goodwill impairment
|
|
|
|
||
|
Impairment charges on assets other than goodwill
|
|
|
|
||
|
Share-based compensation expense
|
|
|
|
||
|
Deferred income tax (benefit) expense
|
(
|
(
|
|
||
|
Pension and other postretirement funding more than cost
|
(
|
(
|
(
|
||
|
Other
|
|
(
|
(
|
||
|
Change in operating assets and liabilities, net of acquisitions and divestitures:
|
|||||
|
Accounts receivable
|
(
|
|
(
|
||
|
Inventories
|
|
|
(
|
||
|
Other assets
|
(
|
|
(
|
||
|
Accounts payable
|
(
|
(
|
(
|
||
|
Income taxes
|
(
|
(
|
|
||
|
Accrued liabilities and other
|
|
|
|
||
|
Net cash provided by operating activities
|
|
|
|
||
|
Investing activities:
|
|||||
|
Capital expenditures
|
(
|
(
|
(
|
||
|
Cash paid for purchase of businesses, net of cash acquired
|
(
|
(
|
(
|
||
|
Proceeds from corporate owned life insurance
|
|
|
|
||
|
Proceeds from sale of property, plant and equipment
|
|
|
|
||
|
Deferred consideration paid
|
(
|
(
|
(
|
||
|
Other
|
|
|
|
||
|
Net cash used for investing activities
|
(
|
(
|
(
|
||
|
Financing activities:
|
|||||
|
Additions to debt
|
|
|
|
||
|
Repayments of debt
|
(
|
(
|
(
|
||
|
Debt issuance costs
|
(
|
|
|
||
|
Changes in commercial paper, net
|
|
|
|
||
|
Other debt additions (repayments), net
|
|
(
|
|
||
|
Repayments of finance lease liabilities
|
(
|
(
|
(
|
||
|
Tax paid in connection with shares withheld from employees
|
(
|
|
|
||
|
Purchases of treasury stock
|
(
|
(
|
(
|
||
|
Share buyback
|
|
|
(
|
||
|
Cash dividends paid to shareholders
|
(
|
(
|
(
|
||
|
Other
|
|
(
|
(
|
||
|
Net cash provided by (used for) financing activities
|
|
(
|
(
|
||
|
Effect of exchange rate changes on cash and cash equivalents
|
(
|
|
(
|
||
|
(Decrease) Increase in cash and cash equivalents
|
(
|
|
(
|
||
|
Cash and cash equivalents at beginning of period
|
|
|
|
||
|
Cash and cash equivalents at end of period
|
$
|
$
|
$
|
||
|
Shares of
Common Stock
|
Common Stock
|
Capital in Excess
of Par Value
|
Treasury Stock
|
Retained
Earnings
|
Accumulated
Other
Comprehensive
Loss
|
Total
Shareholders'
Equity
|
Noncontrolling
Interest (“NCI”)
|
Total
|
|
|
Balance at
December 31, 2021
(1)
|
|
$
|
$
|
$
(
|
$
|
$
(
|
$
|
$
|
$
|
|
Net income
|
—
|
—
|
—
|
—
|
|
—
|
|
|
|
|
Other comprehensive loss, net of tax
|
—
|
—
|
—
|
—
|
—
|
(
|
(
|
—
|
(
|
|
Share-based compensation
|
—
|
—
|
|
—
|
—
|
—
|
|
—
|
|
|
Issuance of common stock
|
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
|
Purchases of treasury stock
|
—
|
—
|
—
|
(
|
—
|
—
|
(
|
—
|
(
|
|
Shares distributed by Smurfit Kappa Employee Trust
|
—
|
—
|
(
|
|
—
|
—
|
|
—
|
|
|
Share buyback
|
—
|
—
|
—
|
(
|
—
|
—
|
(
|
—
|
(
|
|
Cancellation of common stock
|
(
|
—
|
—
|
|
(
|
—
|
|
—
|
|
|
Dividends declared ($
|
—
|
—
|
—
|
—
|
(
|
—
|
(
|
(
|
(
|
|
Balance at
December 31, 2022
|
|
$
|
$
|
$
(
|
$
|
$
(
|
$
|
$
|
$
|
|
Net income
|
—
|
—
|
—
|
—
|
|
—
|
|
|
|
|
Other comprehensive income, net of tax
|
—
|
—
|
—
|
—
|
—
|
|
|
—
|
|
|
Share-based compensation
|
—
|
—
|
|
—
|
—
|
—
|
|
—
|
|
|
Issuance of common stock
|
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
|
Purchases of treasury stock
|
—
|
—
|
—
|
(
|
—
|
—
|
(
|
—
|
(
|
|
Shares distributed by Smurfit Kappa Employee Trust
|
—
|
—
|
(
|
|
—
|
—
|
|
—
|
|
|
Dividends declared ($
|
—
|
—
|
—
|
—
|
(
|
—
|
(
|
—
|
(
|
|
Balance at December 31, 2023
|
|
$
|
$
|
$
(
|
$
|
$
(
|
$
|
$
|
$
|
|
Net income
|
—
|
—
|
—
|
—
|
|
—
|
|
—
|
|
|
Other comprehensive loss, net of tax
|
—
|
—
|
—
|
—
|
—
|
(
|
(
|
—
|
(
|
|
Share-based compensation
|
—
|
—
|
|
—
|
—
|
—
|
|
—
|
|
|
Shares distributed by Smurfit Kappa Employee Trust
|
—
|
—
|
(
|
|
—
|
—
|
|
—
|
|
|
Purchases of treasury stock
|
—
|
—
|
—
|
(
|
—
|
—
|
(
|
—
|
(
|
|
Shares of Smurfit Westrock common stock issued to
WestRock shareholders and NCI assumed as a result of the
Merger
|
|
|
|
—
|
—
|
—
|
|
|
|
|
Converted WestRock RSUs and Options attributable to pre-
Combination services
|
—
|
—
|
|
—
|
—
|
—
|
|
—
|
|
|
Issuance of common stock net of tax paid in connection with
shares withheld from employees
|
|
—
|
|
—
|
(
|
—
|
(
|
—
|
(
|
|
Reclassification from retained earnings to accumulated other
comprehensive loss
|
—
|
—
|
—
|
—
|
(
|
|
|
—
|
|
|
Dividends declared (
$
|
—
|
—
|
|
—
|
(
|
—
|
(
|
—
|
(
|
|
Balance at December 31, 2024
|
|
$
|
$
|
$
(
|
$
|
$
(
|
$
|
$
|
$
|
|
2024
|
|
|
Outstanding payment obligations at the beginning of the fiscal year
|
$
|
|
Assumed as part of the Combination
|
|
|
Amounts added during the period
|
|
|
Amounts settled during the period
|
(
|
|
Balance at end of the fiscal year
|
$
|
|
Cash paid for outstanding WestRock Stock
(a)
|
$
|
|
Smurfit Westrock Shares issued to WestRock Shareholders
(b)
|
|
|
Converted WestRock Options and WestRock RSU Awards attributable to pre-Combination service
(c)
|
|
|
Settlement of pre-existing relationships, trade and other payable and receivable balances with WestRock
(d)
|
(
|
|
Aggregate Merger Consideration
|
$
|
|
Preliminary
Allocation
|
Measurement Period
Adjustments
|
Adjusted Preliminary
Allocation
|
|||
|
Identifiable net assets:
|
|||||
|
Cash and cash equivalents
|
$
|
$
|
$
|
||
|
Accounts receivable
|
|
|
|
||
|
Inventories
|
|
|
|
||
|
Other current assets
|
|
(
|
|
||
|
Property, plant and equipment
|
|
|
|
||
|
Intangibles
|
|
|
|
||
|
Prepaid pension asset
|
|
|
|
||
|
Other non-current assets
|
|
|
|
||
|
Accounts payable
|
(
|
|
(
|
||
|
Accrued compensation and benefits
|
(
|
|
(
|
||
|
Current portion of debt
|
(
|
|
(
|
||
|
Other current liabilities
|
(
|
(
|
(
|
||
|
Non-current debt due after one year
|
(
|
(
|
(
|
||
|
Deferred tax liabilities
|
(
|
|
(
|
||
|
Pension liabilities and other postretirement benefits, net of current
portion
|
(
|
|
(
|
||
|
Other non-current liabilities
|
(
|
(
|
(
|
||
|
Noncontrolling interests
|
(
|
|
(
|
||
|
Identifiable net assets acquired as of July 5, 2024
|
|
|
|
||
|
Goodwill arising on Merger
|
|
(
|
|
||
|
Aggregate Merger Consideration
|
$
|
$
|
$
|
|
Preliminary
Fair Value
|
Weighted
Average Useful
Lives (in years)
|
||
|
Preliminary fair value of intangible assets acquired:
|
|||
|
Customer relationships
|
$
|
|
|
|
Trade names and trademarks
|
|
|
|
|
Developed technology
|
|
|
|
|
Software assets
|
|
|
|
|
Land use rights
|
|
|
|
|
Intangible assets acquired
|
$
|
|
|
Years ended December 31,
|
|||
|
2024
|
2023
|
||
|
Net sales
|
$
|
$
|
|
|
Net income (loss) attributable to common shareholders
|
$
|
$
(
|
|
|
Years ended December 31,
|
|||||
|
2024
|
2023
|
2022
|
|||
|
Net sales (unaffiliated customers)
|
|||||
|
Ireland (country of domicile)
|
$
|
$
|
$
|
||
|
U.S.
|
|
|
|
||
|
Mexico
|
|
|
|
||
|
Germany
|
|
|
|
||
|
France
|
|
|
|
||
|
Other Americas
|
|
|
|
||
|
Other Europe, MEA and APAC
|
|
|
|
||
|
Total
|
$
|
$
|
$
|
||
|
December 31,
|
|||
|
2024
|
2023
|
||
|
Long-lived assets
(1)
|
|||
|
Ireland (country of domicile)
|
$
|
$
|
|
|
U.S.
|
|
|
|
|
Mexico
|
|
|
|
|
Germany
|
|
|
|
|
France
|
|
|
|
|
Other Americas
|
|
|
|
|
Other Europe, MEA and APAC
|
|
|
|
|
Total
|
$
|
$
|
|
|
Year ended December 31, 2024
|
North America
|
Europe, MEA
and APAC
|
LATAM
|
Total
|
|||
|
Net sales (unaffiliated customers)
|
$
|
$
|
$
|
$
|
|||
|
Add net sales (intersegment)
|
|
|
|
|
|||
|
Net sales (aggregate)
|
$
|
$
|
$
|
$
|
|||
|
Less segment expenses:
|
|||||||
|
Segment cost of goods sold
|
$
(
|
$
(
|
$
(
|
$
(
|
|||
|
Segment selling, general and administration expenses
|
(
|
(
|
(
|
(
|
|||
|
$
(
|
$
(
|
$
(
|
$
(
|
||||
|
Segment Adjusted EBITDA
|
$
|
$
|
$
|
$
|
|||
|
Unallocated corporate costs
|
(
|
||||||
|
Depreciation, depletion and amortization
|
(
|
||||||
|
Transaction and integration-related expenses associated with
the Combination
|
(
|
||||||
|
Amortization of fair value step up on inventory
|
(
|
||||||
|
Interest expense, net
|
(
|
||||||
|
Pension and other postretirement non-service expense, net
|
(
|
||||||
|
Share-based compensation expense
|
(
|
||||||
|
Other expense, net
|
(
|
||||||
|
Other adjustments
|
(
|
||||||
|
Income before income taxes
|
$
|
|
Year ended December 31, 2023
|
North America
|
Europe, MEA
and APAC
|
LATAM
|
Total
|
|||
|
Net sales (unaffiliated customers)
|
$
|
$
|
$
|
$
|
|||
|
Add net sales (intersegment)
|
|
|
|
|
|||
|
Net sales (aggregate)
|
$
|
$
|
$
|
$
|
|||
|
Less segment expenses:
|
|||||||
|
Segment cost of goods sold
|
$
(
|
$
(
|
$
(
|
$
(
|
|||
|
Segment selling, general and administration expenses
|
(
|
(
|
(
|
(
|
|||
|
$
(
|
$
(
|
$
(
|
$
(
|
||||
|
Segment Adjusted EBITDA
|
$
|
$
|
$
|
$
|
|||
|
Unallocated corporate costs
|
(
|
||||||
|
Depreciation, depletion and amortization
|
(
|
||||||
|
Transaction and integration-related expenses associated with
the Combination
|
(
|
||||||
|
Interest expense, net
|
(
|
||||||
|
Pension and other postretirement non-service expense, net
|
(
|
||||||
|
Share-based compensation expense
|
(
|
||||||
|
Other expense, net
|
(
|
||||||
|
Other adjustments
|
(
|
||||||
|
Income before income taxes
|
$
|
|
Year ended December 31, 2022
|
North America
|
Europe, MEA
and APAC
|
LATAM
|
Total
|
|||
|
Net sales (unaffiliated customers)
|
$
|
$
|
$
|
$
|
|||
|
Add net sales (intersegment)
|
|
|
|
|
|||
|
Net sales (aggregate)
|
$
|
$
|
$
|
$
|
|||
|
Less segment expenses:
|
|||||||
|
Segment cost of goods sold
|
$
(
|
$
(
|
$
(
|
$
(
|
|||
|
Segment selling, general and administration expenses
|
(
|
(
|
(
|
(
|
|||
|
$
(
|
$
(
|
$
(
|
$
(
|
||||
|
Segment Adjusted EBITDA
|
$
|
$
|
$
|
$
|
|||
|
Unallocated corporate costs
|
(
|
||||||
|
Depreciation, depletion and amortization
|
(
|
||||||
|
Goodwill impairment
|
(
|
||||||
|
Impairment of other assets
|
(
|
||||||
|
Interest expense, net
|
(
|
||||||
|
Pension and other postretirement non-service expense, net
|
(
|
||||||
|
Share-based compensation expense
|
(
|
||||||
|
Other income, net
|
|
||||||
|
Other adjustments
|
(
|
||||||
|
Income before income taxes
|
$
|
|
Years ended December 31,
|
|||||
|
2024
|
2023
|
2022
|
|||
|
Capital expenditures:
|
|||||
|
North America
|
$
|
$
|
$
|
||
|
Europe, MEA and APAC
|
|
|
|
||
|
LATAM
|
|
|
|
||
|
Total per reportable segments
|
$
|
$
|
$
|
||
|
Corporate
|
|
|
|
||
|
Total capital expenditure
|
$
|
$
|
$
|
||
|
Years ended December 31,
|
|||||
|
2024
|
2023
|
2022
|
|||
|
Other significant non-cash charges:
(1)
|
|||||
|
Goodwill impairment
|
|||||
|
LATAM
|
$
|
$
|
$
(
|
||
|
Total goodwill impairment
|
$
|
$
|
$
(
|
||
|
December 31,
|
|||
|
2024
|
2023
|
||
|
Assets:
|
|||
|
North America
|
$
|
$
|
|
|
Europe, MEA and APAC
|
|
|
|
|
LATAM
|
|
|
|
|
Total per reportable segments
|
$
|
$
|
|
|
Corporate
(1)
|
|
|
|
|
Total assets
|
$
|
$
|
|
|
Year ended December 31, 2024
|
|||||||
|
North America
|
Europe, MEA
and APAC
|
LATAM
|
Total
|
||||
|
Revenue by product:
|
|||||||
|
Paper
|
$
|
$
|
$
|
$
|
|||
|
Packaging
|
|
|
|
|
|||
|
Total
|
$
|
$
|
$
|
$
|
|||
|
Year ended December 31, 2023
|
|||||||
|
North America
|
Europe, MEA
and APAC
|
LATAM
|
Total
|
||||
|
Revenue by product:
|
|||||||
|
Paper
|
$
|
$
|
$
|
$
|
|||
|
Packaging
|
|
|
|
|
|||
|
Total
|
$
|
$
|
$
|
$
|
|||
|
Year ended December 31, 2022
|
|||||||
|
North America
|
Europe, MEA
and APAC
|
LATAM
|
Total
|
||||
|
Revenue by product:
|
|||||||
|
Paper
|
$
|
$
|
$
|
$
|
|||
|
Packaging
|
|
|
|
|
|||
|
Total
|
$
|
$
|
$
|
$
|
|||
|
Contract
Assets
(Short-Term)
|
Contract
Liabilities
(Short-Term)
|
||
|
Recorded on the Combination
|
$
|
$
|
|
|
Decrease
|
(
|
(
|
|
|
Ending balance - December 31, 2024
|
$
|
$
|
|
Years ended December 31,
|
|||||
|
2024
|
2023
|
2022
|
|||
|
Transaction-related costs associated with the Combination
|
$
(
|
$
(
|
$
|
||
|
Integration-related costs associated with the Combination
|
(
|
|
|
||
|
Total transaction and integration-related costs associated with the
Combination
|
$
(
|
$
(
|
$
|
||
|
December 31,
|
|||
|
2024
|
2023
|
||
|
Gross accounts receivable
|
$
|
$
|
|
|
Less: Allowances
|
(
|
(
|
|
|
Accounts receivable
|
$
|
$
|
|
|
Years ended December 31,
|
|||||
|
2024
|
2023
|
2022
|
|||
|
Balance at the beginning of the fiscal year
|
$
|
$
|
$
|
||
|
Charges to net sales and selling, general and administrative expenses
|
|
|
|
||
|
Deductions
|
(
|
(
|
(
|
||
|
Write offs
|
(
|
(
|
(
|
||
|
Balance at the end of the fiscal year
|
$
|
$
|
$
|
||
|
December 31,
|
|||
|
2024
|
2023
|
||
|
Finished goods
|
$
|
$
|
|
|
Work-in-progress
|
|
|
|
|
Raw materials
|
|
|
|
|
Consumables and spare parts
|
|
|
|
|
Inventories
|
$
|
$
|
|
|
December 31,
|
|||
|
2024
|
2023
|
||
|
Land and buildings
|
$
|
$
|
|
|
Forestlands
|
|
|
|
|
Plant and equipment
|
|
|
|
|
Construction in progress
|
|
|
|
|
Finance lease right-of-use assets
|
|
|
|
|
Property, plant and equipment at cost
|
|
|
|
|
Less: Accumulated depreciation, depletion and amortization
|
(
|
(
|
|
|
Property, plant and equipment, net
|
$
|
$
|
|
|
North America
|
Europe, MEA
and APAC
|
LATAM
|
Total
|
||||
|
Balance as of December 31, 2022
|
$
|
$
|
$
|
$
|
|||
|
Acquisitions
|
|
|
(
|
(
|
|||
|
Translation adjustment
|
|
|
|
|
|||
|
Balance as of December 31, 2023
|
|
|
|
|
|||
|
Acquisitions
|
|
|
|
|
|||
|
Translation adjustment
|
(
|
(
|
(
|
(
|
|||
|
Balance as of December 31, 2024
|
$
|
$
|
$
|
$
|
|
December 31,
|
|||||||
|
2024
|
2023
|
||||||
|
Gross
Carrying
Amount
|
Accumulated
Amortization
|
Gross
Carrying
Amount
|
Accumulated
Amortization
|
||||
|
Customer relationships
|
$
|
$
(
|
$
|
$
(
|
|||
|
Trade names and trademarks
|
|
(
|
|
(
|
|||
|
Developed technology
|
|
(
|
|
|
|||
|
Software assets
|
|
(
|
|
(
|
|||
|
Land use rights
|
|
|
|
|
|||
|
Total
|
$
|
$
(
|
$
|
$
(
|
|||
|
Year ending December 31, 2025
|
$
|
|
Year ending December 31, 2026
|
|
|
Year ending December 31, 2027
|
|
|
Year ending December 31, 2028
|
|
|
Year ending December 31, 2029
|
|
|
Years ended December 31,
|
|||||
|
2024
|
2023
|
2022
|
|||
|
Interest expense
|
$
(
|
$
(
|
$
(
|
||
|
Interest income
|
|
|
|
||
|
Interest expense, net
|
$
(
|
$
(
|
$
(
|
||
|
Years ended December 31,
|
|||||
|
2024
|
2023
|
2022
|
|||
|
Operating lease costs
|
$
(
|
$
(
|
$
(
|
||
|
Variable and short-term lease costs
|
(
|
(
|
(
|
||
|
Finance lease cost:
|
|||||
|
Amortization of lease assets
|
(
|
(
|
(
|
||
|
Interest on lease liabilities
|
(
|
(
|
(
|
||
|
Lease cost
|
$
(
|
$
(
|
$
(
|
||
|
Balance Sheet Location
|
December 31,
|
||||
|
2024
|
2023
|
||||
|
Operating leases:
|
|||||
|
Operating lease right-of-use assets
|
Other non-current assets
|
$
|
$
|
||
|
Current operating lease liabilities
|
Other current liabilities
|
$
|
$
|
||
|
Non-current operating lease liabilities
|
Other non-current liabilities
|
|
|
||
|
Total operating lease liabilities
|
$
|
$
|
|||
|
Finance leases:
|
|||||
|
Property, plant and equipment
|
Property, plant and equipment, net
|
$
|
$
|
||
|
Accumulated amortization
|
(
|
(
|
|||
|
Property, plant and equipment, net
|
$
|
$
|
|||
|
Current finance lease liabilities
|
Current portion of debt
|
$
|
$
|
||
|
Non-current finance lease liabilities
|
Non-current debt due after one year
|
|
|
||
|
Total finance lease liabilities
|
$
|
$
|
|||
|
Lease Term and Discount Rate
|
December 31,
|
||
|
2024
|
2023
|
||
|
Weighted average remaining lease term:
|
|||
|
Operating leases
|
|
|
|
|
Finance leases
|
|
|
|
|
Weighted average discount rate:
|
|||
|
Operating leases
|
|
|
|
|
Finance leases
|
|
|
|
|
Years ended December 31,
|
|||||
|
2024
|
2023
|
2022
|
|||
|
Cash paid for amounts included in the measurement of lease liabilities:
|
|||||
|
Operating cash flows related to operating leases
|
$
|
$
|
$
|
||
|
Operating cash flows related to finance leases
|
|
|
|
||
|
Financing cash flows related to finance leases
|
|
|
|
||
|
Leased assets obtained in exchange for lease liabilities:
|
|||||
|
Operating leases
|
$
|
$
|
$
|
||
|
Finance leases
|
$
|
$
|
$
|
||
|
Operating
Leases
|
Finance
Leases
|
Total
|
|||
|
Year ending December 31, 2025
|
$
|
$
|
$
|
||
|
Year ending December 31, 2026
|
|
|
|
||
|
Year ending December 31, 2027
|
|
|
|
||
|
Year ending December 31, 2028
|
|
|
|
||
|
Year ending December 31, 2029
|
|
|
|
||
|
Thereafter
|
|
|
|
||
|
Total lease payments
|
$
|
$
|
$
|
||
|
Less: Interest
|
(
|
(
|
(
|
||
|
Present value of future lease payments
|
$
|
$
|
$
|
||
|
2024
|
2023
|
||||||
|
Book Value
|
Fair Value
|
Book Value
|
Fair Value
|
||||
|
Debt with fixed interest rates
|
$
|
$
|
$
|
$
|
|||
|
Level 1
|
Level 2
|
||||||
|
December 31,
|
December 31,
|
||||||
|
2024
|
2023
|
2024
|
2023
|
||||
|
Assets
|
|||||||
|
Other Investments:
|
|||||||
|
Listed
|
$
|
$
|
$
|
$
|
|||
|
Unlisted
|
|
|
|
|
|||
|
Derivatives in cash flow hedging relationships
|
|
|
|
|
|||
|
Derivatives not designated as hedging instruments
|
|
|
|
|
|||
|
Assets measured at fair value
|
$
|
$
|
$
|
$
|
|||
|
Liabilities
|
|||||||
|
Derivatives in cash flow hedging relationships
|
$
|
$
|
$
|
$
|
|||
|
Derivatives not designated as hedging instruments
|
|
|
|
|
|||
|
Liabilities measured at fair value
|
$
|
$
|
$
|
$
|
|||
|
Receivable from financial institutions recognized as part of Combination
|
$
|
|
Receivables sold to the financial institutions and derecognized
|
(
|
|
Receivables collected by financial institutions
|
|
|
Cash proceeds from financial institutions
|
|
|
Receivable from financial institutions at December 31, 2024
|
$
|
|
|
December 31,
|
||||||
|
2024
|
2023
|
||||||
|
Carrying value
|
Weighted
average interest
rate
|
Carrying value
|
Weighted
average interest
rate
|
||||
|
€
|
$
|
|
$
|
|
|||
|
$
|
|
|
|
|
|||
|
€
|
|
|
|
|
|||
|
$
|
|
|
|
|
|||
|
$
|
|
|
|
|
|||
|
€
|
|
|
|
|
|||
|
$
|
|
|
|
|
|||
|
$
|
|
|
|
|
|||
|
Revolving credit facility due 2029
|
|
|
|
|
|||
|
€
|
|
|
|
|
|||
|
€
|
|
|
|
|
|||
|
€
|
|
|
|
|
|||
|
$
|
|
|
|
|
|||
|
$
|
|
|
|
|
|||
|
$
|
|
|
|
|
|||
|
$
|
|
|
|
|
|||
|
$
|
|
|
|
|
|||
|
$
|
|
|
|
|
|||
|
€
|
|
|
|
|
|||
|
€
|
|
|
|
|
|||
|
$
|
|
|
|
|
|||
|
$
|
|
|
|
|
|||
|
$
|
|
|
|
|
|||
|
€
|
|
|
|
|
|||
|
$
|
|
|
|
|
|||
|
$
|
|
|
|
|
|||
|
$
|
|
|
|
|
|||
|
Commercial paper
|
|
|
|
|
|||
|
Vendor financing and commercial card programs
|
|
|
|
|
|||
|
Term loan facilities
|
|
|
|
|
|||
|
Bank loans
|
|
|
|
|
|||
|
Finance lease obligations
|
|
|
|
|
|||
|
Bank overdrafts
|
|
|
|
|
|||
|
Total debt, excluding debt issuance costs
|
|
|
|||||
|
Debt issuance costs
|
(
|
(
|
|||||
|
Total debt
|
|
|
|||||
|
Less: Current portion of debt
|
(
|
(
|
|||||
|
Non-current debt due after one year
|
$
|
$
|
|||||
|
Year ended December 31, 2025
|
$
|
|
Year ended December 31, 2026
|
|
|
Year ended December 31, 2027
|
|
|
Year ended December 31, 2028
|
|
|
Year ended December 31, 2029
|
|
|
Year ended December 31, 2030 and thereafter
|
|
|
Unamortized fair value adjustments, bond discounts and debt issuance costs
|
(
|
|
Total
|
$
|
|
2024
|
2023
|
||
|
Within one year
|
$
|
$
|
|
|
Between one and two years
|
|
|
|
|
More than two years
|
|
|
|
Years ended December 31,
|
|||||
|
2024
|
2023
|
2022
|
|||
|
Deferred Bonus Plan
|
$
|
$
|
$
|
||
|
Performance Share Plan
|
|
|
|
||
|
Performance Share Units
|
|
|
|
||
|
Restricted Stock Units
|
|
|
|
||
|
Total share-based compensation expense
|
$
|
$
|
$
|
||
|
Income tax benefit related to share-based compensation expense
|
$
|
$
|
$
|
||
|
Number of shares
|
Weighted average
grant date
fair value
|
||
|
Outstanding at beginning of year
|
|
$
|
|
|
Granted
|
|
|
|
|
Forfeited
|
(
|
|
|
|
Vested
|
(
|
|
|
|
Outstanding at end of year
|
|
$
|
|
Number of shares
|
Weighted average
grant date
fair value
|
||
|
Outstanding at beginning of year
|
|
$
|
|
|
Granted
|
|
|
|
|
Forfeited
|
(
|
|
|
|
Vested
|
(
|
|
|
|
Lapsed
|
(
|
|
|
|
Outstanding at end of year
|
|
$
|
|
2024
|
2023
|
2022
|
|||
|
Risk-free interest rate (%)
|
|
|
|
||
|
Expected volatility (%)
|
|
|
|
||
|
Expected term (years)
|
|
|
|
|
Number of
shares
|
Weighted
average
grant date
fair value
|
||
|
Outstanding at beginning of year
|
|
$
|
|
|
Granted
|
|
|
|
|
Outstanding at end of year
|
|
$
|
|
Year ended
December 31,
|
|
|
2024
|
|
|
Risk-free interest rate (%)
|
|
|
Expected volatility (%)
|
|
|
Expected term (years)
|
|
|
Number of shares
|
Weighted average
grant date
fair value
|
||
|
Outstanding at beginning of year
|
|
$
|
|
|
Acquired in connection with Combination
|
|
|
|
|
Granted
|
|
|
|
|
Forfeited
|
(
|
|
|
|
Vested
|
(
|
|
|
|
Outstanding at end of year
|
|
$
|
|
Years ended December 31,
|
|||||
|
2024
|
2023
|
2022
|
|||
|
Income before income taxes:
|
|||||
|
Domestic (Ireland)
|
$
|
$
|
$
|
||
|
Foreign (U.S.)
|
(
|
(
|
(
|
||
|
Foreign (Other)
|
|
|
|
||
|
Total income before income taxes
|
$
|
$
|
$
|
||
|
Income tax expense consists of the following components:
|
|||||
|
Current tax expense (net of investment tax credits of
$
|
|||||
|
Domestic (Ireland)
|
$
|
$
|
$
|
||
|
Foreign (U.S., Federal & State)
|
|
|
|
||
|
Foreign (Other)
|
|
|
|
||
|
Total current tax expense
|
$
|
$
|
$
|
||
|
Deferred tax expense (benefit):
|
|||||
|
Domestic (Ireland)
|
$
|
$
|
$
|
||
|
Foreign (U.S., Federal & State)
|
(
|
|
|
||
|
Foreign (Other)
|
(
|
(
|
|
||
|
Total deferred tax (benefit) expense
|
(
|
(
|
|
||
|
Total income tax expense
|
$
|
$
|
$
|
||
|
Years ended December 31,
|
|||||
|
2024
|
2023
|
2022
|
|||
|
Income before income taxes
|
$
|
$
|
$
|
||
|
Income before income taxes multiplied by the statutory income tax rate
|
|
|
|
||
|
Effects of:
|
|||||
|
Income subject to different rates of tax
|
|
|
|
||
|
Change related to outside basis difference in foreign subsidiaries
|
|
|
|
||
|
Change in valuation allowance
|
|
(
|
|
||
|
Uncertain tax positions
|
|
|
|
||
|
U.S. state and local taxes
|
(
|
|
|
||
|
Ireland non-deductible interest
|
|
|
|
||
|
Non-deductible U.S. executive compensation
|
|
|
|
||
|
Non-deductible transaction costs
|
|
|
|
||
|
Other items
|
(
|
(
|
(
|
||
|
Income tax expense
|
$
|
$
|
$
|
||
|
December 31,
|
|||
|
2024
|
2023
|
||
|
Deferred tax assets:
|
|||
|
Pension liabilities and other postretirement benefits
|
$
|
$
|
|
|
Carryforwards
|
|
|
|
|
Lease liabilities
|
|
|
|
|
Accrued expenses
|
|
|
|
|
Stock-based compensation
|
|
|
|
|
Other
|
|
|
|
|
Total
|
$
|
$
|
|
|
Deferred tax liabilities:
|
|||
|
Property, plant and equipment
|
(
|
(
|
|
|
Investments in subsidiaries
|
(
|
(
|
|
|
Prepaid pension asset
|
(
|
|
|
|
Intangibles
|
(
|
(
|
|
|
Inventory reserves
|
(
|
|
|
|
Other non-current assets
|
(
|
|
|
|
Other
|
(
|
(
|
|
|
Total
|
$
(
|
$
(
|
|
|
Valuation allowances
|
(
|
(
|
|
|
Net deferred tax liability
|
$
(
|
$
(
|
|
|
2024
|
2023
|
2022
|
|||
|
Balance at the beginning of the fiscal year
|
$
|
$
|
$
|
||
|
Increases through continuing operations
|
|
|
|
||
|
Reductions through continuing operations
|
(
|
(
|
(
|
||
|
Net change in the valuation allowance through continuing operations
|
|
(
|
|
||
|
Reclassifications related to the disposal of Russian operations
|
|
|
(
|
||
|
Valuation allowances assumed as part of the Combination
|
|
|
|
||
|
Net change in the valuation allowance
|
|
(
|
|
||
|
Balance at the end of the fiscal year
|
$
|
$
|
$
|
|
2024
|
2023
|
2022
|
|||
|
Balance at the beginning of the fiscal year
|
$
|
$
|
$
|
||
|
Additions for tax positions taken in current year
|
|
|
|
||
|
Unrecognized tax benefits acquired as part of the Combination
|
|
|
|
||
|
Additions for tax positions taken in prior years
|
|
|
|
||
|
Reductions for tax positions taken in prior years
|
|
(
|
(
|
||
|
Reductions due to settlements
|
(
|
|
(
|
||
|
Currency translation adjustments
|
(
|
|
|
||
|
Reductions as a result of a lapse of the applicable statute of limitations
|
(
|
(
|
(
|
||
|
Balance at the end of the fiscal year
|
$
|
$
|
$
|
|
Defined Benefit Pension Plans
|
Other Postretirement Benefit Plans
|
||||||||||||||
|
U.S. Plans
|
Non-U.S. Plans
|
U.S. Plans
|
Non-U.S. Plans
|
||||||||||||
|
2024
|
2023
|
2024
|
2023
|
2024
|
2023
|
2024
|
2023
|
||||||||
|
Change in projected benefit obligation:
|
|||||||||||||||
|
Benefit obligation at beginning of year
|
$
|
$
|
$
|
$
|
$
|
$
|
$
|
$
|
|||||||
|
Service cost
|
|
|
|
|
|
|
|
|
|||||||
|
Interest cost
|
|
|
|
|
|
|
|
|
|||||||
|
Plan amendments
|
|
|
(
|
|
|
|
|
|
|||||||
|
Actuarial (gain) loss
|
(
|
|
(
|
|
(
|
|
(
|
|
|||||||
|
Benefits paid
|
(
|
(
|
(
|
(
|
(
|
|
(
|
(
|
|||||||
|
Plan participant contributions
|
|
|
|
|
|
|
|
|
|||||||
|
Curtailments
|
|
|
(
|
|
|
|
|
|
|||||||
|
Settlements
|
|
|
(
|
(
|
|
|
|
|
|||||||
|
Acquisitions
|
|
|
|
|
|
|
|
|
|||||||
|
Other items
|
|
|
|
|
|
|
|
|
|||||||
|
Foreign currency rate changes
|
|
|
(
|
|
|
|
(
|
|
|||||||
|
Benefit obligation at end of year
|
$
|
$
|
$
|
$
|
$
|
$
|
$
|
$
|
|||||||
|
Defined Benefit Pension Plans
|
Other Postretirement Benefit Plans
|
||||||||||||||
|
U.S. Plans
|
Non-U.S. Plans
|
U.S. Plans
|
Non-U.S. Plans
|
||||||||||||
|
2024
|
2023
|
2024
|
2023
|
2024
|
2023
|
2024
|
2023
|
||||||||
|
Change in plan assets:
|
|||||||||||||||
|
Fair value of plan assets at beginning of
year
|
$
|
$
|
$
|
$
|
$
|
$
|
$
|
$
|
|||||||
|
Actual gain on plan assets
|
|
|
|
|
|
|
|
|
|||||||
|
Employer contributions
|
|
|
|
|
|
|
|
|
|||||||
|
Plan participant contributions
|
|
|
|
|
|
|
|
|
|||||||
|
Benefits paid
|
(
|
(
|
(
|
(
|
(
|
|
(
|
(
|
|||||||
|
Settlements
|
|
|
(
|
(
|
|
|
|
|
|||||||
|
Acquisitions
|
|
|
|
|
|
|
|
|
|||||||
|
Foreign currency rate changes
|
|
|
(
|
|
|
|
|
|
|||||||
|
Fair value of plan assets at end of year
|
$
|
$
|
$
|
$
|
$
|
$
|
$
|
$
|
|||||||
|
Funded status at end of year
|
$
|
$
(
|
$
(
|
$
(
|
$
(
|
$
|
$
(
|
$
(
|
|||||||
|
Amounts recognized in the Consolidated
Balance Sheets:
|
|||||||||||||||
|
Non-current assets
|
$
|
$
|
$
|
$
|
$
|
$
|
$
|
$
|
|||||||
|
Current liabilities
|
(
|
(
|
(
|
(
|
(
|
|
(
|
(
|
|||||||
|
Non-current liabilities
|
(
|
(
|
(
|
(
|
(
|
|
(
|
(
|
|||||||
|
Funded status at end of year
|
$
|
$
(
|
$
(
|
(
|
$
(
|
$
|
$
(
|
$
(
|
|||||||
|
Accumulated Benefit Obligation
|
$
|
$
|
$
|
$
|
|||||||||||
|
Defined Benefit Pension Plans
|
Other Postretirement Benefit Plans
|
||||||||||||||
|
U.S. Plans
|
Non-U.S. Plans
|
U.S. Plans
|
Non-U.S. Plans
|
||||||||||||
|
2024
|
2023
|
2024
|
2023
|
2024
|
2023
|
2024
|
2023
|
||||||||
|
Net actuarial loss (gain)
|
$
|
$
|
$
|
$
|
$
(
|
$
|
$
(
|
$
|
|||||||
|
Prior service credit
|
|
|
(
|
(
|
|
|
|
|
|||||||
|
Total accumulated other comprehensive
loss (income)
|
$
|
$
|
$
|
$
|
$
(
|
$
|
$
(
|
$
|
|||||||
|
Defined Benefit Pension Plans
|
Other Postretirement Benefit Plans
|
||||||||||||||
|
U.S. Plans
|
Non-U.S. Plans
|
U.S. Plans
|
Non-U.S. Plans
|
||||||||||||
|
2024
|
2023
|
2024
|
2023
|
2024
|
2023
|
2024
|
2023
|
||||||||
|
Plans with projected benefit obligations in
excess of plan assets:
|
|||||||||||||||
|
Projected benefit obligation
|
$
|
$
|
$
|
$
|
$
—
|
$
—
|
$
—
|
$
—
|
|||||||
|
Accumulated benefit obligation
|
|
|
|
|
—
|
—
|
—
|
—
|
|||||||
|
Fair value of plan assets
|
|
|
|
|
—
|
—
|
—
|
—
|
|||||||
|
Plans with accumulated benefit obligations
in excess of plan assets:
|
|||||||||||||||
|
Accumulated benefit obligation
|
|
|
|
|
—
|
—
|
—
|
—
|
|||||||
|
Fair value of plan assets
|
|
|
|
|
—
|
—
|
—
|
—
|
|||||||
|
Plans with accumulated postretirement
benefit obligations in excess of plan
assets:
|
|||||||||||||||
|
Accumulated postretirement benefit
obligation
|
|
|
|
|
|||||||||||
|
Fair value of plan assets
|
$
|
$
|
$
|
$
|
|||||||||||
|
Defined Benefit Pension Plans
|
Other Postretirement Benefit Plans
|
||||||||||||||||||||||
|
U.S. Plans
|
Non-U.S. Plans
|
U.S. Plans
|
Non-U.S. Plans
|
||||||||||||||||||||
|
2024
|
2023
|
2022
|
2024
|
2023
|
2022
|
2024
|
2023
|
2022
|
2024
|
2023
|
2022
|
||||||||||||
|
Service cost
|
$
|
$
|
$
|
$
|
$
|
$
|
$
|
$
|
$
|
$
|
$
|
$
|
|||||||||||
|
Interest cost
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
|
Expected return on assets
|
(
|
(
|
|
(
|
(
|
(
|
|
|
|
|
|
|
|||||||||||
|
Amortization of:
|
|||||||||||||||||||||||
|
Net actuarial (gain) loss
|
|
(
|
|
|
|
|
|
|
|
|
|
(
|
|||||||||||
|
Prior service credit
|
|
|
|
(
|
(
|
(
|
|
|
|
|
|
|
|||||||||||
|
Curtailment gain
|
|
|
|
(
|
|
|
|
|
|
|
|
|
|||||||||||
|
Settlement loss (gain)
|
|
|
|
|
|
(
|
|
|
|
|
|
|
|||||||||||
|
Other one-time expense
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
|
Net periodic benefit (income) cost
|
$
(
|
$
(
|
$
|
$
|
$
|
$
|
$
|
$
|
$
|
$
|
$
|
$
|
|||||||||||
|
Defined Benefit Pension Plans
|
Other Postretirement Benefit Plans
|
||||||||||||||||||||||
|
U.S. Plans
|
Non-U.S. Plans
|
U.S. Plans
|
Non-U.S. Plans
|
||||||||||||||||||||
|
2024
|
2023
|
2022
|
2024
|
2023
|
2022
|
2024
|
2023
|
2022
|
2024
|
2023
|
2022
|
||||||||||||
|
Net actuarial loss (gain)
|
$
|
$
|
$
(
|
$
(
|
$
|
$
(
|
$
(
|
$
|
$
|
$
(
|
$
|
$
(
|
|||||||||||
|
Prior service (credit) cost arising during the
year
|
|
|
|
(
|
|
(
|
|
|
|
|
|
|
|||||||||||
|
Amortization of prior service credit
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
|
Amortization of actuarial gain (loss) and
settlement gain (loss)
|
|
|
|
(
|
(
|
(
|
|
|
|
|
|
|
|||||||||||
|
Exchange rate (gain) loss
|
|
|
|
(
|
|
(
|
|
|
|
|
|
|
|||||||||||
|
Amount recognized in other comprehensive
loss (income)
|
|
|
(
|
(
|
|
(
|
(
|
|
|
(
|
|
|
|||||||||||
|
Amount recognized in net periodic pension
benefit (income) cost and other
comprehensive loss (income)
|
$
(
|
$
|
$
(
|
$
(
|
$
|
$
(
|
$
|
$
|
$
|
$
|
$
|
$
|
|||||||||||
|
Defined Benefit Pension Plans
|
Other Postretirement Benefit Plans
|
||||||||||||||
|
U.S. Plans
|
Non-U.S. Plans
|
U.S. Plans
|
Non-U.S. Plans
|
||||||||||||
|
2024
|
2023
|
2024
|
2023
|
2024
|
2023
|
2024
|
2023
|
||||||||
|
Discount rate
|
|
|
|
|
|
|
|
|
|||||||
|
Rate of compensation increase
|
|
|
|
|
—
%
|
—
%
|
|
|
|||||||
|
Interest crediting rates
|
|
—
%
|
|
|
—
%
|
—
%
|
—
%
|
—
%
|
|||||||
|
Defined Benefit Pension Plans
|
Other Postretirement Benefit Plans
|
||||||||||||||||||||||
|
U.S. Plans
|
Non-U.S. Plans
|
U.S. Plans
|
Non-U.S. Plans
|
||||||||||||||||||||
|
2024
|
2023
|
2022
|
2024
|
2023
|
2022
|
2024
|
2023
|
2022
|
2024
|
2023
|
2022
|
||||||||||||
|
Discount rate
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
|
Rate of compensation increase
|
|
|
|
|
|
|
—
%
|
—
%
|
—
%
|
|
|
|
|||||||||||
|
Expected long-term rate of return on plan
assets
|
|
|
|
|
|
|
—
%
|
—
%
|
—
%
|
—
%
|
|
|
|||||||||||
|
Interest crediting rates
|
—
%
|
—
%
|
—
%
|
|
|
|
—
%
|
—
%
|
—
%
|
—
%
|
—
%
|
—
%
|
|||||||||||
|
Defined Benefit Pension Plans
|
Other Postretirement Benefit Plans
|
||||||
|
U.S. Plans
|
Non-U.S. Plans
|
U.S. Plans
|
Non-U.S. Plans
|
||||
|
2024
|
2024
|
2024
|
2024
|
||||
|
Equities
|
|
|
|
|
|||
|
Fixed Income
|
|
|
|
|
|||
|
Real Estate
|
|
|
|
|
|||
|
Other (incl. Liability-Driven
Investments (“LDI”))
|
|
|
|
|
|||
|
Defined Benefit Pension Plans
|
|||||||||||||||
|
U.S. Plans
|
|||||||||||||||
|
2024
|
2023
|
||||||||||||||
|
Asset Class
|
Quoted Prices in
Active Markets
For Identical
Assets (Level 1)
|
Significant Other
Observable Inputs
(Level 2)
|
Significant
Unobservable
Inputs (Level 3)
|
Total
|
Quoted Prices in
Active Markets
For Identical
Assets (Level 1)
|
Significant Other
Observable Inputs
(Level 2)
|
Significant
Unobservable
Inputs (Level 3)
|
Total
|
|||||||
|
Cash
|
$
|
$
|
$
|
$
|
$
|
$
|
$
|
$
|
|||||||
|
Equity
|
|
|
|
|
|
|
|
|
|||||||
|
Government Bonds
|
|
|
|
|
|
|
|
|
|||||||
|
Corporate Bonds
|
|
|
|
|
|
|
|
|
|||||||
|
Real Estate / Property
|
|
|
|
|
|
|
|
|
|||||||
|
Insurance Contracts
|
|
|
|
|
|
|
|
|
|||||||
|
Derivatives
|
|
|
|
|
|
|
|
|
|||||||
|
Investment Funds
|
|
|
|
|
|
|
|
|
|||||||
|
Other (incl. LDI)
|
|
|
|
|
|
|
|
|
|||||||
|
Total assets measured using fair value
hierarchy
|
$
|
$
|
$
|
$
|
$
|
$
|
$
|
$
|
|||||||
|
Assets measured at NAV
|
|
|
|||||||||||||
|
Total assets
|
$
|
$
|
|||||||||||||
|
Defined Benefit Pension Plans
|
|||||||||||||||
|
Non-U.S. Plans
|
|||||||||||||||
|
2024
|
2023
|
||||||||||||||
|
Asset Class
|
Quoted Prices in
Active Markets
For Identical
Assets (Level 1)
|
Significant Other
Observable Inputs
(Level 2)
|
Significant
Unobservable
Inputs (Level 3)
|
Total
|
Quoted Prices in
Active Markets
For Identical
Assets (Level 1)
|
Significant Other
Observable Inputs
(Level 2)
|
Significant
Unobservable
Inputs (Level 3)
|
Total
|
|||||||
|
Cash
|
$
|
$
|
$
|
$
|
$
|
$
|
$
|
$
|
|||||||
|
Equity
|
|
|
|
|
|
|
|
|
|||||||
|
Government Bonds
|
|
|
|
|
|
|
|
|
|||||||
|
Corporate Bonds
|
|
|
|
|
|
|
|
|
|||||||
|
Real Estate / Property
|
|
|
|
|
|
|
|
|
|||||||
|
Insurance Contracts
|
|
|
|
|
|
|
|
|
|||||||
|
Derivatives
|
|
(
|
|
(
|
|
(
|
|
(
|
|||||||
|
Investment Funds
|
|
|
|
|
|
|
|
|
|||||||
|
Other (incl. LDI)
|
|
|
|
|
|
|
|
|
|||||||
|
Total assets measured using fair value
hierarchy
|
$
|
$
|
$
|
$
|
$
|
$
|
$
|
$
|
|||||||
|
Assets measured at NAV
|
|
|
|||||||||||||
|
Total assets
|
$
|
$
|
|||||||||||||
|
Other Postretirement Benefit Plans
|
|||||||||||||||
|
Non-U.S. Plans
|
|||||||||||||||
|
2024
|
2023
|
||||||||||||||
|
Asset Class
|
Quoted Prices in
Active Markets
For Identical
Assets (Level 1)
|
Significant Other
Observable
Inputs (Level 2)
|
Significant
Unobservable
Inputs (Level 3)
|
Total
|
Quoted Prices in
Active Markets
For Identical
Assets (Level 1)
|
Significant Other
Observable
Inputs (Level 2)
|
Significant
Unobservable
Inputs (Level 3)
|
Total
|
|||||||
|
Insurance Contracts
|
$
|
$
|
$
|
$
|
$
|
$
|
$
|
$
|
|||||||
|
Total assets measured using fair value
hierarchy
|
$
|
$
|
$
|
$
|
$
|
$
|
$
|
$
|
|||||||
|
Assets measured at NAV
|
|
|
|||||||||||||
|
Total assets
|
$
|
$
|
|||||||||||||
|
Defined Benefit Pension Plans
|
|||||||||||
|
Non-U.S. Plans
|
|||||||||||
|
Balance at December 31, 2023
|
Actual return on plan assets
|
Purchases
|
Sales and settlements
|
Currency Impact
|
Balance at December 31, 2024
|
||||||
|
Equity
|
$
|
$
|
$
|
$
(
|
$
|
$
|
|||||
|
Real Estate / Property
|
|
(
|
|
(
|
(
|
|
|||||
|
Insurance Contracts
|
|
(
|
|
(
|
(
|
|
|||||
|
Other (incl. LDI)
|
|
|
|
(
|
(
|
|
|||||
|
Total assets
|
$
|
$
(
|
$
|
$
(
|
$
(
|
$
|
|||||
|
Other Postretirement Benefit Plans
|
|||||||||||
|
Non-U.S. Plans
|
|||||||||||
|
Balance at December 31, 2023
|
Actual return on plan assets
|
Purchases
|
Sales and settlements
|
Currency Impact
|
Balance at December 31, 2024
|
||||||
|
Insurance Contracts
|
$
|
$
|
$
|
$
(
|
$
|
$
|
|||||
|
Total assets
|
$
|
$
|
$
|
$
(
|
$
|
$
|
|||||
|
Defined Benefit Pension Plans
|
|||||||||||
|
Non-U.S. Plans
|
|||||||||||
|
Balance at December 31, 2022
|
Actual return on plan assets
|
Purchases
|
Sales and settlements
|
Currency Impact
|
Balance at December 31, 2023
|
||||||
|
Equity
|
$
|
$
|
$
|
$
|
$
|
$
|
|||||
|
Real Estate / Property
|
|
|
|
(
|
|
|
|||||
|
Insurance Contracts
|
|
|
|
(
|
|
|
|||||
|
Other (incl. LDI)
|
|
|
|
(
|
|
|
|||||
|
Total assets
|
$
|
$
|
$
|
$
(
|
$
|
$
|
|||||
|
Other Postretirement Benefit Plans
|
|||||||||||
|
Non-U.S. Plans
|
|||||||||||
|
Balance at December 31, 2022
|
Actual return on plan assets
|
Purchases
|
Sales and settlements
|
Currency Impact
|
Balance at December 31, 2023
|
||||||
|
Insurance Contracts
|
$
|
$
|
$
|
$
|
$
|
$
|
|||||
|
Total assets
|
$
|
$
|
$
|
$
|
$
|
$
|
|||||
|
Other Postretirement Benefit Plans
|
|||||||
|
U.S. Plans
|
Non-U.S. Plans
|
||||||
|
Years ended in December 31,
|
|||||||
|
2024
|
2023
|
2024
|
2023
|
||||
|
Health care cost trend rate assumed for next year
|
|
|
|
|
|||
|
Rate to which the cost trend rate gradually declines
|
|
|
|
|
|||
|
Year the rate reaches the ultimate rate
|
|
|
|
—
|
|||
|
Year ending December 31,
|
Defined Benefit Pension Plans
|
Other Postretirement Benefit
Plans
|
||
|
2025
|
$
|
$
|
||
|
2026
|
|
|
||
|
2027
|
|
|
||
|
2028
|
|
|
||
|
2029
|
|
|
||
|
2030-2034
|
|
|
|
Years ended December 31,
|
|||||
|
2024
|
2023
|
2022
|
|||
|
Numerator:
|
|||||
|
Net income attributable to common shareholders
|
$
|
$
|
$
|
||
|
Denominator:
|
|||||
|
Basic weighted average shares outstanding
|
|
|
|
||
|
Effect of dilutive share options
|
|
|
|
||
|
Diluted weighted average shares outstanding
|
|
|
|
||
|
Basic earnings per share attributable to common shareholders
|
$
|
$
|
$
|
||
|
Diluted earnings per share attributable to common shareholders
|
$
|
$
|
$
|
||
|
2025
|
$
|
|
2026
|
|
|
2027
|
|
|
2028
|
|
|
2029
|
|
|
Thereafter
|
|
|
Total
|
$
|
|
December 31,
|
|||
|
2024
|
2023
|
||
|
Assets
|
|||
|
Current assets:
|
|||
|
Cash and cash equivalents
|
$
|
$
|
|
|
Accounts receivable
|
|
|
|
|
Non-current assets:
|
|||
|
Property, plant and equipment, net
|
|
|
|
|
Other non-current assets
|
|
|
|
|
Total assets
|
$
|
$
|
|
|
Liabilities
|
|||
|
Current liabilities:
|
|||
|
Accounts payable
|
$
|
$
|
|
|
Current portion of debt
|
|
|
|
|
Other current liabilities
|
|
|
|
|
Non-current liabilities:
|
|||
|
Non-current debt due after one year
|
|
|
|
|
Other non-current liabilities
|
|
|
|
|
Total liabilities
|
$
|
$
|
|
|
Foreign
Currency
Translation
|
Cash Flow
Hedges
|
Defined Benefit
Pension and
Postretirement
Plans
|
Other Reserves
(1)
|
Total
(2)
|
|
|
Balance at December 31, 2021
|
$
|
$
|
$
|
$
(
|
$
|
|
Other comprehensive loss (income)
|
|
|
(
|
|
|
|
Balance at December 31, 2022
|
$
|
$
|
$
|
$
(
|
$
|
|
Other comprehensive (income) loss
|
(
|
(
|
|
|
(
|
|
Balance at December 31, 2023
|
$
|
$
|
$
|
$
(
|
$
|
|
Other comprehensive loss (income)
|
|
|
(
|
|
|
|
Reclassification from retained earnings
|
|
|
(
|
|
(
|
|
Balance at December 31, 2024
|
$
|
$
|
$
|
$
(
|
$
|
|
Year ended December 31,
|
|||||||||||
|
2024
|
2023
|
2022
|
|||||||||
|
Pre-Tax
|
Tax
|
Net of
Tax
|
Pre-Tax
|
Tax
|
Net of
Tax
|
Pre-Tax
|
Tax
|
Net of
Tax
|
|||
|
Foreign currency translation (loss) gain
|
$
(
|
$
|
$
(
|
$
|
$
|
$
|
$
(
|
$
|
$
(
|
||
|
Defined benefit pension and other post-
retirement benefit plans:
|
|||||||||||
|
Net actuarial gain (loss) arising during
year
|
|
(
|
|
(
|
|
(
|
|
(
|
|
||
|
Amortization and settlement recognition
of net actuarial loss
|
|
(
|
|
|
(
|
|
|
(
|
|
||
|
Prior service credit (cost) arising during
year
|
|
(
|
|
(
|
|
(
|
|
|
|
||
|
Amortization of prior service credit
|
(
|
|
(
|
(
|
|
(
|
(
|
|
(
|
||
|
Foreign currency gain (loss) - pensions
|
|
|
|
(
|
|
(
|
|
|
|
||
|
Derivatives:
|
|||||||||||
|
Changes in fair value of cash flow hedges
|
|
|
|
|
|
|
(
|
|
(
|
||
|
Changes in fair value of cost of hedging
|
|
|
|
|
|
|
(
|
|
(
|
||
|
Consolidated other comprehensive (loss)
income
|
(
|
(
|
(
|
|
|
|
(
|
(
|
(
|
||
|
Less: Other comprehensive loss (income)
attributable to noncontrolling interests
|
|
|
|
|
|
|
|
|
|
||
|
Other comprehensive (loss) income
attributable to common shareholders
|
$
(
|
$
(
|
$
(
|
$
|
$
|
$
|
$
(
|
$
(
|
$
(
|
||
|
Exhibit
Number
|
Description of Exhibit
|
||
|
3.1
|
|||
|
4.1
|
|||
|
4.2
|
|||
|
4.3
|
|||
|
4.4
|
|||
|
4.5
|
|||
|
4.6
|
|||
|
4.7
|
|||
|
10.15#
|
|||
|
10.16#
|
Form of PSU Award Agreement (2024 Award) under the Smurfit Westrock plc 2024 Long-Term Incentive Plan
|
||
|
10.17#
|
Form of RSU Award Agreement (2024 Award for Non-Executive Directors) under the Smurfit Westrock plc 2024 Long-
|
||
|
10.18#
|
|||
|
10.19#
|
|||
|
10.20#
|
|||
|
10.21#
|
|||
|
10.22#
|
|||
|
10.23#
|
|||
|
10.24#
|
|||
|
10.25#
|
|||
|
10.26#
|
|||
|
10.27#
|
|||
|
10.28#
|
|||
|
10.29#
|
|||
|
10.30#
|
|||
|
10.31#
|
|||
|
10.32#
|
|||
|
10.33#
|
|||
|
10.34#
|
|||
|
10.35#
|
|||
|
10.36#
|
|||
|
10.37#
|
|||
|
10.38#
|
|||
|
10.39
|
Registration Rights Agreement, dated as of November 26, 2024, among Smurfit Westrock Financing Designated
Activity Company, the guarantors party thereto and Citigroup Global Markets Inc., ING Financial Markets, LLC,
|
||
|
10.40
|
|||
|
19.1†
|
|||
|
21†
|
|||
|
23
|
Consent of KPMG
, Independent Registered Public Accounting Firm
|
||
|
24
|
Power of Attorney (included on signature page)
|
||
|
31.1†
|
|||
|
31.2†
|
|||
|
32†*
|
|||
|
97.1†
|
|||
|
101.INS
|
Inline XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL
tags are embedded within the Inline XBRL document.**
|
||
|
101.SCH
|
Inline XBRL Taxonomy Extension Schema.**
|
||
|
101.CAL
|
Inline XBRL Taxonomy Extension Calculation Linkbase.**
|
||
|
101.DEF
|
Inline XBRL Taxonomy Extension Definition Document.**
|
||
|
101.LAB
|
Inline XBRL Taxonomy Extension Label Linkbase.**
|
||
|
101.PRE
|
Inline XBRL Taxonomy Extension Presentation Linkbase.**
|
||
|
104
|
Cover Page Interactive Data File––the cover page interactive data file does not appear in the Interactive Data File
because its XBRL tags are embedded within the Inline XBRL document.
|
|
Smurfit Westrock plc
|
||
|
Dated: March 7, 2025
|
/s/ Anthony Smurfit
|
|
|
Name:
|
Anthony Smurfit
|
|
|
Title:
|
President & Group Chief Executive Officer
|
|
|
(Principal Executive Officer)
|
||
|
Signature
|
Title
|
Date
|
||
|
/s/ Anthony Smurfit
|
President & Group Chief Executive Officer and Director
|
March 7, 2025
|
||
|
Anthony Smurfit
|
(Principal Executive Officer)
|
|||
|
/s/ Ken Bowles
|
Executive Vice President & Group Chief Financial Officer and Director
|
March 7, 2025
|
||
|
Ken Bowles
|
(Principal Financial Officer)
|
|||
|
/s/ Irene Page
|
Chief Accounting Officer
|
March 7, 2025
|
||
|
Irene Page
|
(Principal Accounting Officer)
|
|||
|
/s/ Irial Finan
|
Director
|
March 7, 2025
|
||
|
Irial Finan
|
||||
|
/s/ Kaisa Hietala
|
Director
|
March 7, 2025
|
||
|
Kaisa Hietala
|
||||
|
/s/ Colleen F. Arnold
|
Director
|
March 7, 2025
|
||
|
Colleen F. Arnold
|
||||
|
/s/ Timothy J. Bernlohr
|
Director
|
March 7, 2025
|
||
|
Timothy J. Bernlohr
|
||||
|
/s/ Terrell K. Crews
|
Director
|
March 7, 2025
|
||
|
Terrell K. Crews
|
||||
|
/s/ Carol Fairweather
|
Director
|
March 7, 2025
|
||
|
Carol Fairweather
|
||||
|
/s/ Mary Lynn Ferguson-McHugh
|
Director
|
March 7, 2025
|
||
|
Mary Lynn Ferguson-McHugh
|
||||
|
/s/ Suzan F. Harrison
|
Director
|
March 7, 2025
|
||
|
Suzan F. Harrison
|
||||
|
/s/ Lourdes Melgar
|
Director
|
March 7, 2025
|
||
|
Lourdes Melgar
|
||||
|
/s/ Jørgen Buhl Rasmussen
|
Director
|
March 7, 2025
|
||
|
Jørgen Buhl Rasmussen
|
||||
|
/s/ Dmitri L. Stockton
|
Director
|
March 7, 2025
|
||
|
Dmitri L. Stockton
|
||||
|
/s/ Alan D. Wilson
|
Director
|
March 7, 2025
|
||
|
Alan D. Wilson
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|